Structure visualization was performed with Open-Source PyMOL version 2.4.0 (Schrödinger, LLC). R-package MutationalPatterns61 was utilized to reconstruct mutational contexts. For input, we utilized mutations in WTD clusters and data on mutations in humans, the latter of which was extracted from ...
Supplementary Data 2 and Supplementary Data 11 contain a list of the spillover events. For additional information on amino acid substitutions, please refer to Supplementary Data 3. The source data for each subpanel is available in the Source Data file. Full size image...
Source codes for scRNA-seq and Ab repertoire analyses This paper https://github.com/EraslanBas/Sars_Cov2_Antibodies Antibody sequences and scRNA-seq count matrices This paper Single Cell Portal of the Broad Institute (SARS-CoV-2 Antibodies, Accession #SCP1317; https://singlecell.broadinstitute...
This is a good question, so let’s start off with a small part of the very source code of the BioNTech/Pfizer vaccine, also known asBNT162b2, also known as Tozinameranalso known as Comirnaty. First 500 characters of the BNT162b2 mRNA. Source:World Health Organization The BNT162b mRNA...
independent mice.Pvalues were obtained by two-way ANOVA with Sidak’s multiple comparison. For all *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, and source data are provided as a Source Data file or Supplementary information...
Table 1 Vaccine candidates currently in phase 4 of clinical development: As per WHO source, 15th October 2021 Full size table Vaccines candidates and different platforms used for the development of COVID-19 vaccine Every year, 2–3 million fatalities are prevented due to immunization. Numerous ill...
REAGENT or RESOURCESOURCEIDENTIFIER Antibodies: MELC antibodies (Cohort 1) DAPI Roche Cat# 10236276001, N/A CCR2-PE Miltenyi Biotec Cat# 130-118-338, RRID:AB_2751486 CD163-PE Biolegend Cat# 333605, RRID:AB_1134005 CD56-PE Miltenyi Biotec Cat# 130-098-137, RRID:AB_2661200 CD3-PE Milten...
Table. Summary of Studies Included in the Meta-analysis on Bell Palsy and SARS-CoV-2 Vaccination View LargeDownload SourceDesignVaccine type/No. of dosesVaccinated, No. (% total)Age, yNo. (%) of female patientsNo. (%) of patients with Bell palsy El Sahly et al, 2021, US RCTa Mode...
from which the tested samples had been obtained (three reported inclusion of samples from either inpatients and outpatients (n = 1), inpatients and ambulatory patients (n = 1) or inpatients and emergency department patients (n = 1) but did not provide the number of samples from each source)...
Source data are provided with this paper. Code availability Codes and scripts written for this work as well as instructions for running simulations and analysis tools are provided with this paper (see Supplementary Data 1). Change history 29 June 2022 A Correction to this paper has been ...